Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.
Rett syndrome (RTT) is a neurodevelopmental autism spectrum disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Here, we describe the first characterization and neuronal differentiation of induced pluripotent stem (iPS) cells derived from Mecp2-deficient mice. Fully reprogrammed wild-type (WT) and heterozygous female iPS cells express endogenous pluripotency markers, reactivate the X-chromosome and differentiate into the three germ layers. We directed iPS cells to produce glutamatergic neurons, which generated action potentials and formed functional excitatory synapses. iPS cell-derived neurons from heterozygous Mecp2(308) mice showed defects in the generation of evoked action potentials and glutamatergic synaptic transmission, as previously reported in brain slices. Further, we examined electrophysiology features not yet studied with the RTT iPS cell system and discovered that MeCP2-deficient neurons fired fewer action potentials, and displayed decreased action potential amplitude, diminished peak inward currents and higher input resistance relative to WT iPS-derived neurons. Deficiencies in action potential firing and inward currents suggest that disturbed Na(+) channel function may contribute to the dysfunctional RTT neuronal network. These phenotypes were additionally confirmed in neurons derived from independent WT and hemizygous mutant iPS cell lines, indicating that these reproducible deficits are attributable to MeCP2 deficiency. Taken together, these results demonstrate that neuronally differentiated MeCP2-deficient iPS cells recapitulate deficits observed previously in primary neurons, and these identified phenotypes further illustrate the requirement of MeCP2 in neuronal development and/or in the maintenance of normal function. By validating the use of iPS cells to delineate mechanisms underlying RTT pathogenesis, we identify deficiencies that can be targeted for in vitro translational screens.
Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada.
N
N
Farra
W-B
WB
Zhang
P
P
Pasceri
J H
JH
Eubanks
M W
MW
Salter
J
J
Ellis
D000200:Action Potentials / Q000235:genetics / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation / Q000235:genetics; D002460:Cell Line; D004195:Disease Models, Animal; D018698:Glutamic Acid / Q000502:physiology; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics* / Q000502:physiology; D051379:Mice; D008817:Mice, Mutant Strains; D055369:Miniature Postsynaptic Potentials / Q000235:genetics / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D010641:Phenotype; D015518:Rett Syndrome / Q000235:genetics*; D009435:Synaptic Transmission / Q000235:genetics / Q000502:physiology*
C497393:Mecp2 protein, mouse; D051783:Methyl-CpG-Binding Protein 2; D018698:Glutamic Acid